IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans
- PMID: 19038581
- DOI: 10.1016/j.clim.2008.10.006
IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans
Abstract
To evaluate the role of interleukin 14 alpha (IL-14a) in Sjögren's syndrome (SS), we evaluated the expression of IL-14a in the peripheral blood lymphocytes (PBL) of patients with primary and secondary SS and normal controls by quantitative RT-PCR. In addition, transgenic IL-14a mice were analyzed from 6 weeks of age to death for both histological and immunological features of Sjögren's disease. Patients with both primary and secondary Sjögren's syndrome expressed IL-14a at statistically higher levels in their peripheral blood compared to normal controls matched for age, sex and ethnic group. Transgenic mice in which IL-14a expression was increased constitutively were previously demonstrated to develop hypergammaglobulinemia, autoantibodies, infiltration of the parotid glands with lymphocytes, mild immune-complex mediated renal disease and large B cell lymphoma. In this paper we expand these observations to demonstrate that these mice develop all the clinical and immunological features of primary Sjögren's disease in the same relative time frame as patients with primary Sjögren's disease: stage 1-early hypergammaglobulinemia and autoantibody production, stage 2-decreased salivary gland function with early lymphocytic infiltration of the submandibular glands only, but antibody deposition in the submandibular and parotid glands, stage 3-lymphocytic infiltration of the submandibular, parotid and lacrimal glands with B and T lymphocytes and plasma cells along with interstitial lung disease and mild renal disease, and stage 4-large B cell lymphoma. Thus IL-14a is important in the pathophysiology of Sjögren's disease. The IL-14a transgenic mouse is a novel animal model that can be utilized to understand the pathophysiology of Sjögren's disease.
Similar articles
-
A role for lymphotoxin in primary Sjogren's disease.J Immunol. 2010 Nov 15;185(10):6355-63. doi: 10.4049/jimmunol.1001520. Epub 2010 Oct 15. J Immunol. 2010. PMID: 20952683
-
Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.Arthritis Rheum. 2010 Apr;62(4):969-77. doi: 10.1002/art.27318. Arthritis Rheum. 2010. PMID: 20131250
-
Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.J Immunol. 1994 Jun 1;152(11):5532-9. J Immunol. 1994. PMID: 8189070
-
The geoepidemiology of Sjögren's syndrome.Autoimmun Rev. 2010 Mar;9(5):A305-10. doi: 10.1016/j.autrev.2009.11.004. Epub 2009 Nov 10. Autoimmun Rev. 2010. PMID: 19903539 Review.
-
Immunohistopathology of Sjögren's syndrome.Autoimmun Rev. 2006 Nov;6(1):16-20. doi: 10.1016/j.autrev.2006.03.003. Epub 2006 Apr 19. Autoimmun Rev. 2006. PMID: 17110311 Review.
Cited by
-
Advances in understanding the pathogenesis of primary Sjögren's syndrome.Nat Rev Rheumatol. 2013 Sep;9(9):544-56. doi: 10.1038/nrrheum.2013.110. Epub 2013 Jul 16. Nat Rev Rheumatol. 2013. PMID: 23857130 Review.
-
Multiple Roles for B-Lymphocytes in Sjogren's Syndrome.J Clin Med. 2016 Oct 8;5(10):87. doi: 10.3390/jcm5100087. J Clin Med. 2016. PMID: 27740602 Free PMC article. Review.
-
Central role for marginal zone B cells in an animal model of Sjogren's syndrome.Clin Immunol. 2016 Jul;168:30-36. doi: 10.1016/j.clim.2016.04.008. Epub 2016 Apr 30. Clin Immunol. 2016. PMID: 27140729 Free PMC article.
-
IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.Front Immunol. 2021 May 3;12:673658. doi: 10.3389/fimmu.2021.673658. eCollection 2021. Front Immunol. 2021. PMID: 34012457 Free PMC article.
-
IP3R deficit underlies loss of salivary fluid secretion in Sjögren's Syndrome.Sci Rep. 2015 Sep 14;5:13953. doi: 10.1038/srep13953. Sci Rep. 2015. PMID: 26365984 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases